- $24.03bn
- $22.07bn
- $9.69bn
- 80
- 54
- 98
- 91
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 7,428 | 7,566 | 8,970 | 10,580 | 9,687 |
Cost of Revenue | |||||
Gross Profit | 1,579 | 1,629 | 2,207 | 2,918 | 2,636 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 6,377 | 6,447 | 7,327 | 8,288 | 7,731 |
Operating Profit | 1,051 | 1,119 | 1,644 | 2,293 | 1,956 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 1,026 | 1,078 | 1,590 | 2,253 | 1,928 |
Provision for Income Taxes | |||||
Net Income After Taxes | 879 | 901 | 1,237 | 1,726 | 1,592 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 879 | 901 | 1,237 | 1,726 | 1,592 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 879 | 901 | 1,237 | 1,726 | 1,592 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 221 | 230 | 316 | 498 | 463 |